ResMed | RMD - 贸易债权人

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.94B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	贸易债权人	更改		日
Ansell	USD 302.3M		51.4M	2025-12
Artivion	USD 18.34M		2.3M	2026-03
AtriCure	USD 70.06M		8.34M	2026-03
Baxter International	USD 1.09B		87M	2026-03
Cochlear	AUD 281.3M		17.1M	2025-12
Cooper Companies	USD 225.8M		74.6M	2025-12
CSL	USD 3.17B		290M	2025-12
Dexcom	USD 1.94B		109.1M	2026-03
Edwards Lifesciences	USD 181.1M		46.4M	2026-03
Fisher Paykel Healthcare	NZD 267.8M		4M	2025-12
Globus Medical	USD 103.66M		4.81M	2026-03
Haemonetics	USD 51.06M		2.36M	2026-03
Idexx Laboratories	USD 129.97M		19.57M	2026-03
Inogen	USD 21.22M		684K	2025-09
Insulet	USD 149.8M		74.8M	2026-03
Integra LifeSciences	USD 87.95M		7.78M	2026-03
Intuitive Surgical	USD 1.85B		68.6M	2026-03
Masimo	USD 89M		14M	2026-03
Medtronic	USD 2.57B		12M	2025-12
Philips	EUR 1.99B		63M	2026-03
Ramsay Health Care	AUD 2.02B		289.9M	2025-12
ResMed	USD 273.3M		22.9M	2026-03
Sigma Healthcare	AUD 1.32B		970.03M	2025-12
Sonic Healthcare	AUD 313.54M		543.93M	2024-06
Steris	USD 338.8M		53.7M	2026-03
Teleflex	USD 143.63M		13.43M	2026-03
Thermo Fisher Scientific	USD 3.34B		278M	2026-03